Administration of human chorionic gonadotropin with a controlled-release function to immature rats for application in male infertility therapy.
Biodegradable poly(DL-lactic acid) (PLA) devices with controlled release of human chorionic gonadotropin (hCG) were fabricated in a 2-mm cylinder form by the meltpressing technique. The devices fabricated were inserted subcutaneously in the backs of immature rats. It was found that the serum level of testosterone (T) remained constant at approximately 0.7 ng/ml for an experimental period of 14 days, resulting in greater Leydig cell production of testosterone. This was also suggested from the results of immunohistochemical observation of the testis and weight changes of prostates, such as the ventral prostates and seminal vesicle.
Okabe
K
K
Department of Urology, School of Medicine Gunma University, Japan.
Shibata
Y
Y
Mashimo
T
T
Yuasa
H
H
Yamanaka
H
H
Asano
M
M
Yoshida
M
M
D020341:Absorbable Implants; D000818:Animals; D006063:Chorionic Gonadotropin / Q000008:administration & dosage* / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D004195:Disease Models, Animal; D007150:Immunohistochemistry; D007248:Infertility, Male / Q000188:drug therapy* / Q000662:veterinary; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013737:Testis / Q000033:anatomy & histology; D013739:Testosterone / Q000097:blood
D006063:Chorionic Gonadotropin; D003692:Delayed-Action Preparations; D013739:Testosterone